CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS Group
Issuer: CureVac / Key word(s): Annual Results
24.04.2024 / 13:06 CET/CEST
The issuer is solely responsible for the..
Issuer: CureVac / Key word(s): Annual Results
24.04.2024 / 13:06 CET/CEST
The issuer is solely responsible for the..
19 April 2024
*Biodexa Pharmaceuticals PLC*
(“Biodexa” or the “Company” or, together with its subsidiaries,..
In this episode, my guest is Dr. David Yeager, Ph.D., professor of psychology at the University of Texas, Austin, and the author of..